Rottenstein Law Group Considers With Some Misgivings Dismissal of Claims Against Generic Fosamax Man

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that claims in the Fosamax femur fracture multidistrict litigation have been dismissed as against some generic manufacturers of the product. New York, NY (PRWEB) December 08, 2011 As the representative of claimants who allegedly suffered harm as a result of having taken Fosamax or its generic equivalent, the attorneys at the Rottenstein Law Group lament this decision’s potential to prevent victims who took only Fosamax’s generic equivalent from recovering f
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations